Stimulant drugs — primarily cocaine and methamphetamine — are among the most commonly misused substances in the United States. While they do not produce the physically dangerous withdrawal associated with alcohol or benzodiazepines, stimulant use disorders carry serious health, psychological, and social consequences that respond well to structured professional treatment. For NYSHIP and Empire Plan members, federal parity law ensures that such treatment must be covered on par with care for other medical conditions.
This article is for informational purposes only and is not a substitute for professional medical advice. If you or someone you know needs help, please contact a qualified healthcare provider or call 988.
Stimulants work primarily by flooding the brain's reward system with dopamine — the chemical associated with pleasure, motivation, and reinforcement. According to the National Institute on Drug Abuse (NIDA), repeated stimulant use alters the brain's dopamine system, reducing the ability to experience pleasure from everyday rewards and driving compulsive drug-seeking. Over time, higher doses are needed to produce the same effect — a hallmark of developing dependence.
MedlinePlus, a service of the National Library of Medicine, describes stimulant use disorder as a pattern of use that causes significant problems in daily life despite continued harm. Signs may include:
Methamphetamine use disorder shares many of these signs but can progress more rapidly and may produce more pronounced cognitive and physical effects over time.
Unlike alcohol or benzodiazepine withdrawal — which can be life-threatening and requires medical supervision — stimulant withdrawal is not typically medically dangerous. However, it can be intensely uncomfortable. Common symptoms include:
These symptoms can last days to weeks. The psychological discomfort — especially depressive symptoms — is a major driver of early relapse. Medically supervised withdrawal management is still recommended: clinicians can monitor mood closely, screen for suicidal ideation, and ensure safety during this vulnerable period.
Currently, no medications are FDA-approved specifically for cocaine or methamphetamine use disorder, though research is active. Behavioral therapies remain the most effective and well-supported approaches. According to SAMHSA, treatment for stimulant use disorder works, and recovery is achievable:
Stimulant use disorders frequently co-occur with depression, anxiety, and post-traumatic stress. In some cases, stimulant use began as a way to self-medicate an underlying mood condition. Treating the substance use disorder alone — without addressing these underlying issues — often leads to incomplete recovery. Integrated treatment programs that address both addiction and mental health together, sometimes called dual diagnosis treatment, produce consistently better long-term outcomes.
If you are a New York State employee or covered dependent enrolled in NYSHIP or the Empire Plan, federal mental health parity law applies to your coverage. As explained by the Centers for Medicare & Medicaid Services (CMS), the Mental Health Parity and Addiction Equity Act (MHPAEA) requires that insurers not impose stricter limitations on substance use disorder treatment than on comparable medical or surgical care. NYSHIP cannot apply higher co-pays, more restrictive prior authorization, or lower visit limits for addiction treatment than for other conditions.
Coverage for stimulant use disorder may include medically supervised detox, residential rehabilitation, partial hospitalization (PHP), intensive outpatient programming (IOP), and outpatient counseling. Exact benefits depend on your enrollment tier and plan year. Before seeking care, use the NYSHIP coverage verification process to get a clear picture of your current benefits.
If you or a family member is struggling with stimulant use, you do not have to navigate this alone. NYSHIP Detox works with Empire Plan members to access evidence-based care. Call 213-321-6518 to speak with an admissions specialist. You can also reach SAMHSA's National Helpline at 1-800-662-4357 — free, confidential, available 24/7. If you or someone you know is in crisis, call or text 988 to reach the Suicide and Crisis Lifeline.
We confirm your exact NYSHIP / Empire Plan coverage and report back, usually within a few hours. HIPAA & 42 CFR Part 2 protected.
Call 213-321-6518